Bacitracin

杆菌肽

Report date: 2025/04/23 14:50:48

Base Information

Drug NameBacitracin
Drug Alias NameFortracin枯草菌素Penitracin枯草菌肽Topitracin +[10] 
ClassificationBiologics > Protein drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParanasal Sinus DiseasesBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1945/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHui Zhi Pharmaceutical (Dalian) Co Ltd
Inactive CompaniesSteward St. Elizabeth'S Medical Center Of Boston Inc
Active IndicationsBacterial Infections
Inactive IndicationsParanasal Sinus Diseases

Other Information

ATC CodeD06AX05J01XX10R02AB04
Related LinksWikipediaDrugBankKEGG